JFS Wealth Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$42 | – | 1971 |
|
|
2024
Q4 | $42 | Sell |
3
-39
| -93% | -$546 | ﹤0.01% | 1912 |
|
|
2024
Q3 | $1.15K | Buy |
42
+6
| +17% | +$164 | ﹤0.01% | 1664 |
|
|
2024
Q2 | $881 | Hold |
36
| – | – | ﹤0.01% | 1693 |
|
|
2024
Q1 | $768 | Buy |
36
+17
| +89% | +$363 | ﹤0.01% | 1718 |
|
|
2023
Q4 | $364 | Buy |
19
+7
| +58% | +$134 | ﹤0.01% | 1844 |
|
|
2023
Q3 | $193 | Sell |
12
-14
| -54% | -$225 | ﹤0.01% | 1866 |
|
|
2023
Q2 | $603 | Hold |
26
| – | – | ﹤0.01% | 1730 |
|
|
2023
Q1 | $604 | Buy |
26
+6
| +30% | +$139 | ﹤0.01% | 1694 |
|
|
2022
Q4 | $290 | Buy |
20
+11
| +122% | +$160 | ﹤0.01% | 1805 |
|
|
2022
Q3 | $0 | Buy |
9
+2
| +29% | – | ﹤0.01% | 1858 |
|
|
2022
Q2 | $0 | Sell |
7
-11
| -61% | – | ﹤0.01% | 1868 |
|
|
2022
Q1 | $0 | Buy |
18
+12
| +200% | – | ﹤0.01% | 1912 |
|
|
2021
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 1822 |
|